NPI registry status
Active
2026 NPPES data Optometrist NPI 1316564461 OD
Verify on CMS → Anthony Barbiero, OD
Optometrist in Monroe, Louisiana.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 61,426 in Optometrist, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
979
Medicare Part D claims · 342 beneficiaries · Optometrist avg: 279
Generic prescribing
63%
generic claims · 37% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
94.8/100
▲ 11 pts above national avg 83.5 · Exceptional
Industry payments
$288.33
8 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Anthony Barbiero, OD reported a CMS MIPS final score of 94.8/100 - above the 83.5 national average - and filed 979 Medicare Part D claims in 2024.
- 94.8/100
- MIPS score · +11 vs avg
- 979
- Part D claims, 2024
- 63%
- generic prescribing
- $288.33
- industry payments (Sunshine Act)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Anthony Barbiero, OD
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1316564461), first enumerated 07/06/2020.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 979 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 94.8/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Hospital affiliations
1 CMS Care Compare hospital affiliation on record — practice footprint from the Doctors and Clinicians file.
Source: CMS Care Compare
- Reported
Industry payment transparency
$288.33 in reported industry payments (8 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1316564461 · Optometrist
NPI-10 · ENUM-RECENT · TAX-MEGA · MIPS-ELITE · RX-LIGHT · BOOK-LIGHT · PHOTO-FINISH
- NPI-10 1316564461
- ENUM-RECENT 2020
- TAX-MEGA 61K Optometrist
- MIPS-ELITE 94.8/100
- RX-LIGHT 979
- BOOK-LIGHT 528 in Louisiana
- PHOTO-FINISH Melissa Sherman · ±0.0
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Barbiero · this …
Barbiero · this provider
94.8 MIPS pts
- Auzita Sajjadi ·…
Auzita Sajjadi
94.8 MIPS pts
- Sabre Wright · n…
Sabre Wright
94.8 MIPS pts
- Melissa Sherman …
Melissa Sherman
94.8 MIPS pts
- Shannon Huntzber…
Shannon Huntzberry
94.8 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Anthony Barbiero, OD's MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
95 ≥ 73rd percentile 73% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Anthony Barbiero, OD sits
This provider among optometrist peers
Across the 6,187 optometrist providers who report both Medicare Part D prescribing and a MIPS quality score, Anthony Barbiero, OD writes more Part D claims than 85% of them and scores higher on MIPS quality than 75% - placing this provider in the high-volume, high-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one optometrist peer from a representative sample of 60; the gold marker is Anthony Barbiero, OD. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
What does the federal data show about Anthony Barbiero, OD?
High performer (top quartile)Primary specialty
Optometrist
Medicare Part D claims
979 251% vs specialty avg
MIPS final score
94.8/100 11.3 pts vs avg
Specialty distribution in Louisiana
How Optometrist compares to other specialties among Louisiana providers
Medicare quality performance, MIPS
Anthony Barbiero, OD's 2023 MIPS final score plotted against the Optometrist national average
- MIPS Final Score
- 94.8/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1316564461 |
|---|---|
| Specialty | Optometrist |
| Credentials | OD |
| Gender | Male |
| NPI Issued | 07/06/2020 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
94.8235
Final Score
Measured-score avg: 83.5
90.5882
Quality
100
Promoting Interoperability
Reporting: Group practice
Hospital and facility affiliations
Facilities where Anthony Barbiero, OD bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" - a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
WK Pierremont Eye Institute
Shreveport, LA
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Anthony Barbiero, OD. Source: openpaymentsdata.cms.gov.
Total received
$288
Largest payer
Dompe US, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Anthony Barbiero, OD - brand share 37.0%
Optometrist average
37% brand-name claims vs 63% generic, on 979 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
979
Total Claims
$118K
Total Drug Cost
342
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 1,678.533
- Total Day Supply
- 47,506
- Brand vs Generic
- 37% brand / 63% generic
- Brand Drug Cost
- $102K
- Generic Drug Cost
- $16K
Patient Demographics
- Average Patient Age
- 73.3 years
- Avg HCC Risk Score
- 1.19
- Gender Split
- 64% female / 36% male
- Age Distribution
- <65: 38, 65-74: 162, 75-84: 102, 85+: 40
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Anthony Barbiero, OD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Latanoprost
Latanoprost
382 claims
- Timolol Maleate 93
Timolol Maleate
93 claims
- Brimonidine Tartrate 85
Brimonidine Tartrate
85 claims
- Prednisolone Acetate 75
Prednisolone Acetate
75 claims
- Dorzolamide-Timolol 66
Dorzolamide-Timolol
66 claims
- Brimonidine Tartra… 46
Brimonidine Tartrate-Timolol
46 claims
- Restasis 23
Restasis
23 claims
- Combigan 21
Combigan
21 claims
| Drug | Claims |
|---|---|
| Latanoprost | 382 |
| Timolol Maleate | 93 |
| Brimonidine Tartrate | 85 |
| Prednisolone Acetate | 75 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 66 |
| Brimonidine Tartrate-Timolol Brimonidine Tartrate/Timolol | 46 |
| Restasis Cyclosporine | 23 |
| Combigan Brimonidine Tartrate/Timolol | 21 |
| Ketorolac Tromethamine | 19 |
| Cequa Cyclosporine | 16 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Optometrist Overview
How Anthony Barbiero, OD fits within the Optometrist landscape nationally.
61,426
Optometrist Providers in US
56
States with Optometrist
279
Avg Claims per Provider
Anthony Barbiero, OD's 979 claims are above the specialty average of 279.
Nationwide Optometrist peers with similar MIPS or enrollment year
Two federal-record peer sets for Barbiero, both outside Louisiana so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (94.8 here).
Same NPPES enumeration year (2020)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Optometrist Providers in Louisiana
Other clinicians with the same primary specialty enrolled in Louisiana, drawn from the same CMS NPPES roster as Barbiero.
One of 528 Optometrist providers enrolled in Louisiana, 5 are shown here.
Dr. Scott Abbott
O.D.
Baton Rouge, LA
Dr. Kennedy Achord
OD
Baton Rouge, LA
Dr. Shonda Achord
O.D.
Baton Rouge, LA
Dr. Weston Acosta
OD
Covington, LA
Dr. Charles Adams
OD
Bossier City, LA
Compare Optometrist nationally: see state-by-state distribution →
Frequently Asked Questions
What is Anthony Barbiero, OD's specialty? ▼
Anthony Barbiero, OD specializes in Optometrist and practices in Monroe, Louisiana. Credentials: OD.
How much does Anthony Barbiero, OD prescribe under Medicare Part D? ▼
In 2024, Anthony Barbiero, OD wrote 979 Medicare Part D claims totaling $118K in drug costs for 342 beneficiaries.
What is Anthony Barbiero, OD's Medicare quality score? ▼
Anthony Barbiero, OD has a CMS MIPS Final Score of 94.8/100 (Quality: 90.6). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Anthony Barbiero, OD located? ▼
Anthony Barbiero, OD is located at 3000 FORSYTHE AVE, Monroe, LA, 71201. Phone: (318) 807-2020.
What is Anthony Barbiero, OD's NPI number? ▼
Anthony Barbiero, OD's National Provider Identifier (NPI) is 1316564461, issued on 07/06/2020.
Does Anthony Barbiero, OD prescribe more brand-name or generic drugs? ▼
Anthony Barbiero, OD's prescribing is 37% brand-name and 63% generic drugs by claim count, with $102K in brand drug costs.
How many Optometrist providers are there in the US? ▼
There are 61,426 Optometrist providers across 56 states in the US. The average Optometrist provider writes 279 Medicare Part D claims per year.
What drugs does Anthony Barbiero, OD prescribe most often? ▼
Based on 2024 Medicare Part D data, Anthony Barbiero, OD's most frequently prescribed drugs include Latanoprost, Timolol Maleate, Brimonidine Tartrate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Anthony Barbiero, OD accept Medicare? ▼
Anthony Barbiero, OD appears in CMS Medicare data with 979 Part D claims and 342 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Anthony Barbiero, OD's credentials? ▼
Anthony Barbiero, OD's NPI is 1316564461 with credentials OD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.